Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Hilfiker MA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Behm, DJ, Aiyar, NV, Olzinski, AR, McAtee, JJ, Hilfiker, MA, Dodson, JW, Dowdell, SE, Wang, GZ, Goodman, KB, Sehon, CA, Harpel, MR, Willette, RN, Neeb, MJ, Leach, CA, Douglas, SA, Behm, D J, Aiyar, N V, Olzinski, A R, McAtee, J J, Hilfiker, M A
Publikováno v:
British Journal of Pharmacology; Sep2010, Vol. 161 Issue 1, p207-228, 22p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Krstic Dimitrije, Madhusudan Amrita, Doehner Jana, Vogel Prisca, Notter Tina, Imhof Claudine, Manalastas Abigail, Hilfiker Martina, Pfister Sandra, Schwerdel Cornelia, Riether Carsten, Meyer Urs, Knuesel Irene
Publikováno v:
Journal of Neuroinflammation, Vol 9, Iss 1, p 151 (2012)
Abstract Background Alzheimer’s disease (AD) is the most prevalent form of age-related dementia, and its effect on society increases exponentially as the population ages. Accumulating evidence suggests that neuroinflammation, mediated by the brain
Externí odkaz:
https://doaj.org/article/40597797b2bc4701b4f9d98a4fb41160
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Brooks CA; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Barton LS; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Behm DJ; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Eidam HS; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Fox RM; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Hammond M; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Hoang TH; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Holt DA; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Hilfiker MA; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Lawhorn BG; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Patterson JR; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Stoy P; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Roethke TJ; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Ye G; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Zhao S; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Thorneloe KS; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Goodman KB; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Cheung M; Heart Failure Discovery Performance Unit, GlaxoSmithKline, Metabolic Pathways and Cardiovascular Therapeutic Area, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2019 Jul 15; Vol. 10 (8), pp. 1228-1233. Date of Electronic Publication: 2019 Jul 15 (Print Publication: 2019).
Autor:
Kallander LS; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Washburn D; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Hilfiker MA; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Eidam HS; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Lawhorn BG; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Prendergast J; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Fox R; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Dowdell S; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Manns S; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Hoang T; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Zhao S; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Ye G; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Hammond M; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Holt DA; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Roethke T; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Hong X; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Reid RA; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Gampe R; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Zhang H; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Diaz E; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Rendina AR; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Quinn AM; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States., Willette B; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2018 Jul 02; Vol. 9 (7), pp. 736-740. Date of Electronic Publication: 2018 Jul 02 (Print Publication: 2018).
Autor:
Hilfiker MA; Departments of Chemistry, Biology, and Drug Metabolism and Pharmacokinetics, Metabolic Pathways and Cardiovascular Therapeutic Area Unit, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Hoang TH; Departments of Chemistry, Biology, and Drug Metabolism and Pharmacokinetics, Metabolic Pathways and Cardiovascular Therapeutic Area Unit, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Cornil J; Departments of Chemistry, Biology, and Drug Metabolism and Pharmacokinetics, Metabolic Pathways and Cardiovascular Therapeutic Area Unit, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Eidam HS; Departments of Chemistry, Biology, and Drug Metabolism and Pharmacokinetics, Metabolic Pathways and Cardiovascular Therapeutic Area Unit, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Matasic DS; Departments of Chemistry, Biology, and Drug Metabolism and Pharmacokinetics, Metabolic Pathways and Cardiovascular Therapeutic Area Unit, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Roethke TJ; Departments of Chemistry, Biology, and Drug Metabolism and Pharmacokinetics, Metabolic Pathways and Cardiovascular Therapeutic Area Unit, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Klein M; Platform Technology and Science, Molecular Discovery Research, GlaxoSmithKline , 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States., Thorneloe KS; Departments of Chemistry, Biology, and Drug Metabolism and Pharmacokinetics, Metabolic Pathways and Cardiovascular Therapeutic Area Unit, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Cheung M; Departments of Chemistry, Biology, and Drug Metabolism and Pharmacokinetics, Metabolic Pathways and Cardiovascular Therapeutic Area Unit, GlaxoSmithKline , 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2013 Jan 27; Vol. 4 (2), pp. 293-6. Date of Electronic Publication: 2013 Jan 27 (Print Publication: 2013).
Autor:
Hilfiker MA; Department of Medicinal Chemistry, Metabolic Pathways Center of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals, 709 Swedeland Road, King of Prussia, PA 19406, United States. mark.a.hilfiker@gsk.com, Wang N, Hou X, Du Z, Pullen MA, Nord M, Nagilla R, Fries HE, Wu CW, Sulpizio AC, Jaworski JP, Morrow D, Edwards RM, Jin J
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2009 Aug 01; Vol. 19 (15), pp. 4292-5. Date of Electronic Publication: 2009 May 27.
Autor:
Hilfiker MA; Department of Medicinal Chemistry, Cardiovascular and Urogenital Center of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals, 709 Swedeland Road, PO Box 1539, King of Prussia, PA 19406, USA. mark.a.hilfiker@gsk.com, Zhang D, Dowdell SE, Goodman KB, McAtee JJ, Dodson JW, Viet AQ, Wang GZ, Sehon CA, Behm DJ, Wu Z, Carballo LH, Douglas SA, Neeb MJ
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2008 Aug 15; Vol. 18 (16), pp. 4470-3. Date of Electronic Publication: 2008 Jul 20.